Royalty Pharma plc (RPRX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 1.43B | 619M | 1.85B | 1.52B | 1.84B | 1.8B | 1.79B | 2.58B | 1.56B | 1.27B | 1.73B | 2.95B |
| Cash & Short-Term Investments | 608.29M | 637.5M | 955.04M | 1.49B | 1.82B | 1.77B | 1.76B | 2.55B | 1.53B | 1.23B | 1.68B | 2.91B |
| Cash Only | 586.39M | 619M | 938.94M | 631.91M | 1.09B | 929.03M | 950.05M | 1.76B | 843M | 477.01M | 936.45M | 2.17B |
| Short-Term Investments | 21.9M | 18.8M | 16.1M | 856.14M | 728.66M | 841.97M | 814.27M | 788.6M | 689.48M | 756.74M | 747.46M | 735.01M |
| Accounts Receivable | 807.36M | 883.7M | 888.97M | 27.74M | 23.79M | 26.96M | 24.9M | 23.58M | 22.23M | 22.41M | 37.91M | 35.23M |
| Days Sales Outstanding | 120.6 | 131.1 | 69.21 | 4.05 | 4.02 | 4.02 | 3.95 | 3.88 | 3.58 | 4.65 | 6.27 | 6.23 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 10.16M | -902.2M | 5.52M | 4.45M | 3.08M | 4.19M | 4.97M | 2.29M | 5.01M | 18.04M | 6.78M | 10.22M |
| Total Non-Current Assets | 18.39B | 17.06B | 17.5B | 16.8B | 15.77B | 16.42B | 16.25B | 15.08B | 14.57B | 15.11B | 14.13B | 14.17B |
| Property, Plant & Equipment | 0 | 0 | 19.8M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Asset Turnover | - | - | 30.77x | - | - | - | - | - | - | - | - | - |
| Goodwill | 924.63M | 924.63M | 924.63M | 924.63M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 16.54B | 0 | 5.32M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 845.77M | 880.28M | 722.85M | 15.79B | 15.73B | 16.39B | 16.21B | 15.05B | 14.57B | 15.1B | 14.11B | 14.14B |
| Other Non-Current Assets | 76.85M | 15.26B | 15.83B | 85.49M | 36.71M | 33.53M | 42.79M | 27.55M | 4.49M | 6.52M | 20.21M | 29.41M |
| Total Assets | 19.82B | 19.62B | 19.35B | 18.32B | 17.61B | 18.22B | 18.04B | 17.66B | 16.13B | 16.38B | 15.86B | 17.12B |
| Asset Turnover | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.03x | 0.04x | 0.03x | 0.03x |
| Asset Growth % | 12.53% | 7.67% | 7.23% | 3.77% | 9.16% | 11.24% | 13.79% | 3.13% | -5.52% | -2.57% | -10.28% | -3.49% |
| Total Current Liabilities | 535.68M | 636.21M | 530.8M | 1.21B | 1.18B | 1.25B | 1.17B | 275.7M | 124.57M | 161.38M | 127.93M | 1.17B |
| Accounts Payable | 25.48M | 19.4M | 41.41M | 20.21M | 37.63M | 13.37M | 22.05M | 23.42M | 11.55M | 15.16M | 13.63M | 5.81M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 380M | 380M | 380M | 999.44M | 998.61M | 997.77M | 996.94M | 0 | 0 | 0 | 0 | 999.37M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 130.2M | 236.81M | 77.22M | 3.08M | 18.6M | 68.6M | 31.2M | 97.49M | 9.02M | 11.38M | 0 | 0 |
| Current Ratio | 2.66x | 0.97x | 3.48x | 1.26x | 1.56x | 1.44x | 1.54x | 9.35x | 12.52x | 7.90x | 13.51x | 2.52x |
| Quick Ratio | 2.66x | 0.97x | 3.48x | 1.26x | 1.56x | 1.44x | 1.54x | 9.35x | 12.52x | 7.90x | 13.51x | 2.52x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 9.34B | 9.27B | 9.2B | 7.61B | 6.64B | 6.63B | 6.62B | 7.63B | 6.14B | 6.14B | 6.14B | 6.14B |
| Long-Term Debt | 8.58B | 8.57B | 8.57B | 7B | 6.62B | 6.61B | 6.61B | 7.6B | 6.14B | 6.14B | 6.13B | 6.13B |
| Capital Lease Obligations | 0 | 16.1M | 16.9M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 766.46M | 682.61M | 612.98M | 610.47M | 17.9M | 12.08M | 5.58M | 27.04M | 3.22M | 900K | 11.3M | 8.5M |
| Total Liabilities | 9.88B | 9.91B | 9.73B | 8.82B | 7.82B | 7.88B | 7.78B | 7.9B | 6.27B | 6.3B | 6.27B | 7.31B |
| Total Debt | 8.96B | 8.95B | 8.97B | 8B | 7.62B | 7.61B | 7.61B | 7.6B | 6.14B | 6.14B | 6.13B | 7.13B |
| Net Debt | 8.37B | 8.33B | 8.03B | 7.37B | 6.53B | 6.68B | 6.66B | 5.84B | 5.3B | 5.66B | 5.19B | 4.95B |
| Debt / Equity | 0.90x | 0.92x | 0.93x | 0.84x | 0.78x | 0.74x | 0.74x | 0.78x | 0.62x | 0.61x | 0.64x | 0.73x |
| Debt / EBITDA | 15.91x | 22.98x | 20.93x | 50.23x | 15.27x | 19.03x | 8.72x | 31.23x | 153.64x | 8.02x | 36.47x | 17.89x |
| Net Debt / EBITDA | 14.87x | 21.39x | 18.74x | 46.27x | 13.09x | 16.70x | 7.63x | 23.98x | 132.55x | 7.40x | 30.90x | 12.44x |
| Interest Coverage | 5.99x | 4.78x | 6.58x | 2.32x | 7.64x | 6.08x | 13.12x | 4.97x | 0.90x | 16.19x | 3.65x | 8.48x |
| Total Equity | 9.94B | 9.71B | 9.62B | 9.5B | 9.79B | 10.34B | 10.26B | 9.75B | 9.86B | 10.08B | 9.59B | 9.81B |
| Equity Growth % | 1.51% | -6.07% | -6.22% | -2.55% | -0.76% | 2.56% | 7.03% | -0.63% | 0.42% | 5.87% | -7.98% | -5.71% |
| Book Value per Share | 17.76 | 17.36 | 17.19 | 16.90 | 16.93 | 17.56 | 17.30 | 16.34 | 16.51 | 16.75 | 15.94 | 16.20 |
| Total Shareholders' Equity | 6.89B | 6.48B | 6.41B | 6.35B | 6.69B | 6.95B | 6.87B | 6.48B | 6.5B | 6.53B | 6.14B | 6.28B |
| Common Stock | 45K | 106K | 107K | 107K | 106K | 108K | 108K | 108K | 108K | 108K | 108K | 109K |
| Retained Earnings | 2.51B | 2.36B | 2.3B | 2.22B | 2.48B | 2.85B | 2.76B | 2.38B | 2.43B | 2.52B | 2.13B | 2.25B |
| Treasury Stock | -2.71M | -2.61M | -2.61M | -2.61M | -2.65M | -2.66M | -2.66M | -2.66M | -2.65M | -2.63M | -2.62M | -2.63M |
| Accumulated OCI | 63K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 3.05B | 3.24B | 3.21B | 3.16B | 3.1B | 3.4B | 3.39B | 3.28B | 3.36B | 3.56B | 3.45B | 3.53B |